Cargando…

Clinicopathological analysis of PD-L2 expression in colorectal cancer

BACKGROUND: (PD-L2), a ligand of programmed cell death protein 1 (PD-1), is an inhibitory receptor of T cells and activated B cells. Many studies have focused on PD-L1, another ligand of PD-1, and the prognostic significance of PD-L1 has been reported in many tumors. However, the expression of PD-L2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Peng-Da, Sun, Zhong-Wen, Lai, Hui-Jun, Yang, Jie, Wu, Ping-Ping, Guo, Yun-Di, Sun, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219115/ https://www.ncbi.nlm.nih.gov/pubmed/30464512 http://dx.doi.org/10.2147/OTT.S177329

Ejemplares similares

Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a meta-analysis
por: Wang, Shuxia, et al.
Publicado: (2020)

PD‐L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
por: Lee, Sze‐Hwei, et al.
Publicado: (2021)

The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis
por: Xu, Gang, et al.
Publicado: (2019)

The Prognostic and Clinicopathological Roles of PD-L1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Li, Yan, et al.
Publicado: (2019)

Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a systematic review and meta-analysis
por: Shen, Zefeng, et al.
Publicado: (2019)

Clinicopathological assessment of PD-1/PD-L1 immune checkpoint expression in desmoid tumors
por: Hashimoto, Kazuhiko, et al.
Publicado: (2023)

Correlation of PIK3CA mutation with programmed death ligand-1 (PD-L1) expression and their clinicopathological significance in colorectal cancer
por: Ahn, Ae Ri, et al.
Publicado: (2021)

Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factors
por: Igarashi, Tomoyuki, et al.
Publicado: (2016)

Integrative assessment of clinicopathological parameters and the expression of PD-L1, PD-L2 and PD-1 in tumor cells of retroperitoneal sarcoma
por: Miyake, Makito, et al.
Publicado: (2020)

Clinicopathological values of PD-L1 expression in HER2-positive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2019)

PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
por: Bai, Yanhua, et al.
Publicado: (2017)

Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors
por: Guo, Hua, et al.
Publicado: (2020)

Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer
por: Zeng, Jun, et al.
Publicado: (2017)

Prognostic and clinicopathological value of PD-L1 in colorectal cancer: a systematic review and meta-analysis
por: Yang, Lianzhou, et al.
Publicado: (2019)

PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population
por: Rong, Lulu, et al.
Publicado: (2019)

PD-L1 Expression in Medullary Thyroid Carcinoma and Its Association with Clinicopathological Findings
por: Kemal, Yasemin, et al.
Publicado: (2022)

Clinicopathological and prognostic implications of vessels encapsulate tumor clusters with PD-L1 in intrahepatic cholangiocarcinoma patients
por: Tao, Ping, et al.
Publicado: (2020)

PD‐L1/PD‐L1 signalling promotes colorectal cancer cell migration ability through RAS/MEK/ERK
por: Cao, Yihui, et al.
Publicado: (2022)

Clinicopathological and prognostic significance of PD-L1 expression in sarcoma: A systematic review and meta-analysis
por: Zheng, Chuanxi, et al.
Publicado: (2018)

Clinicopathological and Prognostic Significance of Immunoscore and PD-L1 in Intrahepatic Cholangiocarcinoma
por: Wu, Hong, et al.
Publicado: (2021)

Clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis
por: Ding, Xiangli, et al.
Publicado: (2019)

Immunoexpression of PD-L1 and PD-1 and Its Clinicopathological Correlation in Urothelial Carcinomas
por: Kumar, Utpal, et al.
Publicado: (2021)

Clinicopathologic Correlation With Expression of PD-L1 on Both Tumor Cells and Tumor-infiltrating Immune Cells in Patients With Non–Small Cell Lung Cancer
por: Song, Peng, et al.
Publicado: (2019)

Clinicopathological Significance of microRNA-31, -143 and -145 Expression in Colorectal Cancer
por: Wang, Chao-Jie, et al.
Publicado: (2009)

Clinicopathologic Implications of PIWIL2 Expression in Colorectal Cancer
por: Oh, Sun-Ju, et al.
Publicado: (2012)

Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics
por: Zhang, Jie, et al.
Publicado: (2015)

Expression of Survivin and Cortactin in Colorectal Adenocarcinoma: Association with Clinicopathological Parameters
por: Lee, Ying-Yu, et al.
Publicado: (2009)

Risk Analysis of Positive PD-L1 Expression and Clinicopathological Features and Survival Prognosis in Patients with Colorectal Cancer: Systematic Review and Meta-Analysis
por: Tang, Maocai, et al.
Publicado: (2022)

Clinicopathological Characteristics of TZAP Expression in Colorectal Cancers
por: Jung, Soo-Jung, et al.
Publicado: (2020)

Correlation between the Expression of PD-L1 and Clinicopathological Features in Patients with Thymic Epithelial Tumors
por: Chen, Yanmei, et al.
Publicado: (2018)

Clinicopathological significance and prognostic implications of Ube2v1 expression in colorectal cancer
por: Ma, Qiang, et al.
Publicado: (2023)

Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis
por: Zhu, Lei, et al.
Publicado: (2019)

Prognostic and Clinicopathological Role of PD-L1 in Endometrial Cancer: A Meta-Analysis
por: Lu, Ling, et al.
Publicado: (2020)

PTEN Loss Increases PD-L1 Protein Expression and Affects the Correlation between PD-L1 Expression and Clinical Parameters in Colorectal Cancer
por: Song, Minmin, et al.
Publicado: (2013)

Retracted: Risk Analysis of Positive PD-L1 Expression and Clinicopathological Features and Survival Prognosis in Patients with Colorectal Cancer: Systematic Review and Meta-Analysis
por: Healthcare Engineering, Journal of
Publicado: (2023)

Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients
por: Deng, Min, et al.
Publicado: (2021)

Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence
por: Cui, Lixuan, et al.
Publicado: (2022)

Retrospective analysis of the prognostic value of PD-L1 expression and (18)F-FDG PET/CT metabolic parameters in colorectal cancer
por: Jiang, Hao, et al.
Publicado: (2020)

Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer
por: Li, Yue, et al.
Publicado: (2022)

Expression of PD-1/PD-L1 in primary breast tumours and metastatic axillary lymph nodes and its correlation with clinicopathological parameters
por: Yuan, Chenxi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2uu6d2bl1igip0g72hp6s9b56o